Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks

• click to rate

  Posted by Two Blokes Jul 9 - Filed in Stock - 2 views
  
  GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.